Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10358436 Kinase inhibitors and method of treating cancer

Patent 10358436 was granted and assigned to University Health Network on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11858915 Polo like kinase 4 inhibitors
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+149 characters)
Article

Patent abstract

The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Bryan T. Forrest0
Heinz W. Pauls0
Louise G. Edwards0
Miklos Feher0
Narendra Kumar B. Patel0
Peter Brent Sampson0
Radoslaw Laufer0
Sze-Wan Li0
Yong Liu0
Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11667627 Salt and crystal forms of PLK-4 inhibitor
0
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103584360
Edits on 6 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
University Health Network
0
Current Assignee
‌
University Health Network
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103584360
Date of Patent
July 23, 2019
0
Patent Application Number
159021430
Date Filed
February 22, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103584360
Patent Citations Received
‌
US Patent 10919886 Salt and crystal forms of PLK-4 inhibitor
0
Patent Primary Examiner
‌
Samantha L Shterengarts
0
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10358436
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10919886 Salt and crystal forms of PLK-4 inhibitor
Edits on 27 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10358436 Kinase inhibitors and method of treating cancer

Infobox
Is a
Patent
Patent
Patent applicant
‌
University Health Network
Current assignee
‌
University Health Network
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10358436
Date of patent
July 23, 2019
Patent application number
15902143
Date Filed
February 22, 2018
Patent primary examiner
‌
Samantha L Shterengarts

Find more entities like US Patent 10358436 Kinase inhibitors and method of treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.